Princess Margaret Cancer Center

Toronto, Ontario

We've found

5 trials

at this facility

Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Toronto,

Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Toronto,

Alvocidib Biomarker-driven Phase 2 AML Study

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Toronto,

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Toronto,

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Toronto,

Use our guide to learn which trials are right for you!